Expression of cancer stem cell markers, CD133, CD44 and OCT-4, in small cell lung cancer and their clinical significances
10.3760/cma.j.issn.1006-9801.2015.07.007
- VernacularTitle:肿瘤干细胞标志物CD133、CD44、OCT-4在小细胞肺癌中的表达及其临床意义
- Author:
Yajun JI
;
Ling BAI
;
Xin WANG
;
Zhenghong LIU
- Publication Type:Journal Article
- Keywords:
CD133;
CD44;
OCT-4;
Cancer stem cell;
Small cell lung cancer
- From:
Cancer Research and Clinic
2015;(7):458-460,464
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the expression of cancer stem cell markers, CD133, CD44 and OCT-4, in small cell lung cancer cell line NCI-H82 and confirm the specific markers. Methods NCI-H82 cells were cultured, and the expressions of markers (CD133, CD44 and OCT-4) were detected by immunofluorescence staining. The immunohistochemistry was performed to detect the expressions of CD133, CD44 and OCT-4 in 79 tissues with small cell lung cancer. Results In NCI-H82 cells, the florescence was positive in CD133 and CD44 and negative in OCT-4. In the tissues, the expression of CD133 and CD 44 was related with tumor size, lymph node metastasis and clinical stage (P< 0.05), while OCT-4 was negative expression. Conclusion CD133 and CD44 might be the cancer stem cell markers of small cell lung cancer, which maybe have clinical significance on diagnosis and treatment.